M. Pharm
Assistant Professor
School of Pharmacy and Life Sciences
 
Department: NA
Phone: 9937772257
 

About Me

Completed M. Pharm in the year 2019 from Siksha 'o' Anusandhan (Deemed to be University), Bhubaneswar, Odisha with specialization in Pharmacology.  I have guided 6 under graduate students. Currently pursuing my Ph.D. in Pharmacy under Centurion University of Technology and Management, Bhubaneswar, Odisha.  I have actively involved myself in product development like cream, and gel.


 
Research Fields

  • Nanotechnology
  • Pharmaceutical Formulation and Development

Teaching

  • Pharmaceutics
  • Pharmaceutical Engineering
  • Remedial Biology
  • Human anatomy and physiology
  • Pharmaceutical Jurisprudence
  • Health Education and Community Pharmacy

Expertise

  • Ocular drug delivery
  • Nanotechnology
  • Formulation and development and BIOVIA (Discovery studio)

Interests

  • Novel Drug Delivery System

 
   

Research Fields

Aspirin is widely used acidic nonsteroidal anti-inflammatory drug. Antioxidant and cytoprotective activity has been suggested by many reports and research is still going on for further in-depth study. Cytoprotection in the corneal epithelium has been undertaken using aspirin-in-hydrogel formulation in rat eye model. HPMC hydrogel matrix formulation was prepared by solvent casting technique. Redox-induced corneal cell damage was monitored by applying ferric chloride and pyknotic cells were viewed by histological assessment and quantified by image j software. Aspirin treated group showed a recovery in corneal cell injury as compared to ferric chloride-induced group. The cytoprotective activity of aspirin might be due to scavenging OH- radicals. Aspirin acted as a chemical trap for hydroxyl radicals, the most damaging reactive oxygen and thus inhibited NF-kB activation. This antioxidant property of aspirin probably has protected the corneal cell from the damage induced by ferric chloride and hence aspirin could be a better option for corneal cell protection. Also the signs of carrageenan induced acute inflammation have been inhibited completely just within 2 h of placing the film in the rabbit eye. Both the drug release and corneal permeation have been sustained due to the presence of HPMC K100M in all the films and have exhibited diffusion controlled mechanism. Relatively more sustained drug release and permeation was noticed when polymer content increased in the film (67.39 and 69.51 % respectively at the end of 6 h). In conclusion, aspirin film formulation could be utilized for sustained activity in corneal cell protection and ocular inflammation with better patient compliance.